Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation

Archives of Surgery

Volumn 137, Issue 5, 2002, Pages 572-576

  Holt, David ^a   Thomas, Ryan ^a   Van Thiel, David ^a   Brems, John J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; AGED; ANTIBODY TITER; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG EFFICACY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME; VIRUS TRANSMISSION;

EID: 0036244729     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.137.5.572     Document Type: Conference Paper

References (8)

1. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease
2. "Occult" hepatitis B virus as a source of infection in liver transplant recipients
3. Infectivity of hepatic allografts with antibodies to hepatic hepatitis B virus
4. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen
5. Prevention of de novo hepatitis B infections in recipients of hepatic allografts from anti-HBc positive donors
6. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine
7. Antibody response to hepatitis B virus vaccination in individuals with hepatitis C virus infection
8. Vaccination of patients with liver disease: Who, when and how